Andreas Pahl

Company: Heidelberg Pharma Research GmbH

Job title: CSO & Executive Vice President

Seminars:

BCMA-ATAC: Updates on a Novel Mode of Action in Cancer Therapy 2:00 pm

Read more

day: Day One